Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Diabetes

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1794514

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1794514

Needle Free Diabetes Care

PUBLISHED:
PAGES: 284 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Needle Free Diabetes Care Market to Reach US$16.8 Billion by 2030

The global market for Needle Free Diabetes Care estimated at US$13.1 Billion in the year 2024, is expected to reach US$16.8 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2024-2030. Insulin Infuser, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$5.6 Billion by the end of the analysis period. Growth in the Insulin Patches segment is estimated at 5.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.6 Billion While China is Forecast to Grow at 7.5% CAGR

The Needle Free Diabetes Care market in the U.S. is estimated at US$3.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.4 Billion by the year 2030 trailing a CAGR of 7.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 3.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global Needle-Free Diabetes Care Market - Key Trends & Drivers Summarized

Why Is Needle-Free Diabetes Care Attracting Attention in Chronic Disease Management?

Needle-free diabetes care technologies are being developed and adopted to address the discomfort, inconvenience, and risks associated with traditional needle-based methods of glucose monitoring and insulin delivery. For many patients, repeated finger-pricking and insulin injections cause pain, skin irritation, and anxiety, which can impact adherence to treatment. Needle-free systems aim to improve patient compliance by offering painless, user-friendly, and non-invasive or minimally invasive alternatives.

These technologies include transdermal patches, jet injectors, laser-based devices, microneedle arrays, and non-invasive glucose monitors that use interstitial fluid, sweat, or optical signals. Wearable continuous glucose monitors (CGMs) and smart sensors are increasingly replacing manual monitoring. Devices that integrate insulin delivery with monitoring capabilities are also emerging, allowing for more precise and personalized glycemic control. The increasing emphasis on quality of life and long-term disease self-management is fueling interest in these innovative tools.

How Are Emerging Technologies Enhancing Accessibility and Efficiency?

Advancements in biosensor technology, miniaturization, and wireless communication are driving development of more accurate and responsive needle-free solutions. CGMs using skin sensors now transmit real-time data to smartphones or insulin pumps, enabling continuous tracking without physical disruption. Jet injectors, which deliver insulin through high-pressure streams without needles, are being refined to offer better dosing accuracy and reduced tissue trauma.

Non-invasive blood glucose monitoring devices using optical, electromagnetic, or ultrasound signals are under active research, although achieving reliable accuracy remains a challenge. Digital health platforms are increasingly linked with these devices, allowing remote monitoring by healthcare providers and integration into broader chronic care ecosystems. Battery efficiency, user interface design, and data visualization tools are being improved to support daily usability and broader adoption.

Which End-Users and Care Models Are Driving Demand for Needle-Free Solutions?

The primary users of needle-free diabetes devices include type 1 and type 2 diabetes patients seeking comfort, convenience, and better treatment adherence. Pediatric patients, elderly individuals, and needle-phobic users are particularly likely to benefit from non-invasive options. Home-based and remote care models are helping expand demand for self-operated and wearable solutions that minimize clinic visits while maintaining control.

Healthcare providers and diabetes educators are also incorporating needle-free devices into patient management plans to improve engagement and reduce complications. Pharmacies, telemedicine platforms, and insurance providers are beginning to support these devices as part of personalized health plans. In regions with high diabetes prevalence and limited clinical infrastructure, needle-free technologies offer scalable alternatives that reduce the burden on traditional healthcare systems.

Growth in the Needle-Free Diabetes Care Market Is Driven by Several Factors…

Growth in the needle-free diabetes care market is driven by several factors. Increasing diabetes prevalence worldwide demands better and more patient-friendly management tools. Advancements in sensor technology, wearable electronics, and wireless data integration improve device performance and user experience. Rising awareness of self-monitoring and long-term disease control supports consumer adoption. Expansion of digital health ecosystems encourages the integration of needle-free devices with mobile apps and cloud platforms. Pediatric and geriatric care models favor painless solutions that improve safety and compliance. Regulatory approvals and investment in non-invasive diagnostics are accelerating product development and market entry across multiple regions.

SCOPE OF STUDY:

The report analyzes the Needle Free Diabetes Care market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Device Type (Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps, Jet Injectors); End-Use (Homecare End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • 3M Company
  • Akeso/D. Medical Industries (Spring pump)
  • Akra Dermojet
  • Antares Pharma, Inc.
  • Bioject Medical Technologies, Inc.
  • CeQur Corporation
  • Crossject SA
  • Echo Therapeutics Inc.
  • Endo International plc
  • European Pharma Group BV
  • Injex Pharma AG
  • Insulet Corporation (Omnipod)
  • Johnson & Johnson
  • MannKind Corporation
  • Medtronic PLC
  • NuGen Medical Devices (InsuJet)
  • Pancreum LLC
  • PharmaJet, Inc.
  • Tandem Diabetes Care, Inc.
  • Valeritas, Inc.
  • Zogenix, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP37488

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Needle Free Diabetes Care - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Discomfort With Traditional Injections Spurs Demand for Needle-Free Diabetes Management Solutions
    • Increased Adoption of Jet Injectors and Transdermal Delivery Systems Throws Spotlight on Pain-Free Alternatives
    • Rising Diabetes Prevalence Globally Strengthens Business Case for User-Friendly, Non-Invasive Technologies
    • OEM Innovation in Patch-Based and Microneedle-Free Insulin Delivery Enhances Convenience and Compliance
    • Advancements in Continuous Glucose Monitoring (CGM) and Non-Invasive Sensors Drive System Integration
    • Patient Preference for Less Intrusive, Home-Based Care Supports Transition to Needle-Free Devices
    • Technological Breakthroughs in Ultrasonic, Iontophoretic, and Laser-Based Insulin Delivery Propel Market Differentiation
    • Government Focus on Improving Diabetes Management Infrastructure Encourages Inclusion of New Delivery Options
    • Growing Pediatric and Geriatric Diabetic Population Fuels Need for Gentle and Easy-to-Use Delivery Methods
    • Expansion of Telemedicine and Remote Patient Monitoring Strengthens Use of Portable Needle-Free Devices
    • Shift Toward Wearable and App-Connected Devices Supports Adoption in Tech-Savvy Urban Populations
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Needle Free Diabetes Care Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Needle Free Diabetes Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Needle Free Diabetes Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Insulin Infuser by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Insulin Infuser by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Insulin Infuser by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Insulin Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Insulin Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Insulin Patches by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Insulin Pens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Insulin Pens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Insulin Pens by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Insulin Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Insulin Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Insulin Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Jet Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Jet Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Jet Injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Homecare End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Homecare End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Homecare End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • JAPAN
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • CHINA
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: China 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: China 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • EUROPE
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Needle Free Diabetes Care by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Needle Free Diabetes Care by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • FRANCE
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: France 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: France 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • GERMANY
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Needle Free Diabetes Care by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Needle Free Diabetes Care by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • INDIA
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: India 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: India 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Needle Free Diabetes Care by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Needle Free Diabetes Care by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Needle Free Diabetes Care by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Needle Free Diabetes Care by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • AFRICA
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!